Phase II trial of vorinostat in advanced melanoma
Haas, N. B., Quirt, I., Hotte, S., McWhirter, E., Polintan, R., Litwin, S., Adams, P. D., McBryan, T., Wang, L., Martin, L. P., vonMehren, M., Alpaugh, R. K., Zweibel, J., Oza, A.
Published in Investigational new drugs (01.06.2014)
Published in Investigational new drugs (01.06.2014)
Get full text
Journal Article
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Hansen, A.R., Massard, C., Ott, P.A., Haas, N.B., Lopez, J.S., Ejadi, S., Wallmark, J.M., Keam, B., Delord, J.-P., Aggarwal, R., Gould, M., Yang, P., Keefe, S.M., Piha-Paul, S.A.
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population
Buti, S., Puligandla, M., Bersanelli, M., DiPaola, R.S., Manola, J., Taguchi, S., Haas, N.B.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo
Yao, K, Gietema, J A, Shida, S, Selvakumaran, M, Fonrose, X, Haas, N B, Testa, J, O'Dwyer, P J
Published in British journal of cancer (12.12.2005)
Published in British journal of cancer (12.12.2005)
Get full text
Journal Article
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma
Voss, M.H., Hussain, A., Vogelzang, N., Lee, J.L., Keam, B., Rha, S.Y., Vaishampayan, U., Harris, W.B., Richey, S., Randall, J.M., Shaffer, D., Cohn, A., Crowell, T., Li, J., Senderowicz, A., Stone, E., Figlin, R., Motzer, R.J., Haas, N.B., Hutson, T.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Keefe, S.M., Hoffman-Censits, J., Cohen, R.B., Mamtani, R., Heitjan, D., Eliasof, S., Nixon, A., Turnbull, B., Garmey, E.G., Gunnarsson, O., Waliki, M., Ciconte, J., Jayaraman, L., Senderowicz, A., Tellez, A.B., Hennessy, M., Piscitelli, A., Vaughn, D., Smith, A., Haas, N.B.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population
Buti, S., Puligandla, M., Bersanelli, M., DiPaola, R.S., Manola, J., Taguchi, S., Haas, N.B.
Published in Annals of oncology (01.07.2018)
Published in Annals of oncology (01.07.2018)
Get full text
Journal Article
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
Harshman, L C, Drake, C G, Haas, N B, Manola, J, Puligandla, M, Signoretti, S, Cella, D, Gupta, R T, Bhatt, R, Van Allen, E, Lara, P, Choueiri, T K, Kapoor, A, Heng, D Y C, Shuch, B, Jewett, M, George, D, Michaelson, D, Carducci, M A, McDermott, D, Allaf, M
Published in Kidney cancer (26.07.2017)
Published in Kidney cancer (26.07.2017)
Get full text
Journal Article
DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic region
Haas, Naomi B., Cantwell, Carrie A., Johnson, Peter F., Burch, John B. E.
Published in Molecular and Cellular Biology (01.04.1995)
Published in Molecular and Cellular Biology (01.04.1995)
Get full text
Journal Article
Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly
HAAS, N. B, LACRETA, F. P, WALCZAK, J, HUDES, G. R, BRENNAN, J. M, OZOLS, R. F, O'DWYER, P. J
Published in Cancer research (Chicago, Ill.) (01.03.1994)
Get full text
Published in Cancer research (Chicago, Ill.) (01.03.1994)
Journal Article
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N, Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B, Sawrycki, Piotr, Gurney, Howard, Chevreau, Christine, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Burke, John M, Doshi, Gurjyot, Topart, Delphine, Oudard, Stephane, Hammers, Hans, Kitamura, Hiroshi, Bedke, Jens, Perini, Rodolfo F, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David I, Powles, Thomas
Published in The New England journal of medicine (19.08.2021)
Published in The New England journal of medicine (19.08.2021)
Get full text
Journal Article
Clinical, pharmacokinetic and biological studies of topotecan
O'Dwyer, P J, LaCreta, F P, Haas, N B, Halbherr, T, Frucht, H, Goosenberg, E, Yao, K S
Published in Cancer chemotherapy and pharmacology (01.01.1994)
Published in Cancer chemotherapy and pharmacology (01.01.1994)
Get more information
Journal Article
Phase I trial of 5-fluorouracil by 24-hour infusion weekly
Haas, N B, Hines, J B, Hudes, G R, Johnston, N, Ozols, R F, O'Dwyer, P J
Published in Investigational new drugs (01.06.1993)
Published in Investigational new drugs (01.06.1993)
Get more information
Journal Article
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Symeonides, Stefan N., Hajek, Jaroslav, Chang, Yen-Hwa, Lee, Jae-Lyun, Sarwar, Naveed, Haas, Naomi B., Gurney, Howard, Sawrycki, Piotr, Mahave, Mauricio, Gross-Goupil, Marine, Zhang, Tian, Burke, John M., Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Oudard, Stephane, Topart, Delphine, Hammers, Hans, Kitamura, Hiroshi, McDermott, David F., Silva, Adriano, Winquist, Eric, Cornell, Jerry, Elfiky, Aymen, Burgents, Joseph E., Perini, Rodolfo F., Powles, Thomas
Published in The New England journal of medicine (18.04.2024)
Published in The New England journal of medicine (18.04.2024)
Get full text
Journal Article
158PPlasma KIM-1 is associated with clinical outcomes after resection for localized renal cell carcinoma: A trial of the ECOG-ACRIN Research Group (E2805)
Xu, W, Puligandla, M, Haas, N B, Flaherty, K T, Uzzo, R G, Sabbisetti, V, Dutcher, J J, DiPaola, R S, Bhatt, R S
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer
Haas, N B, Schilder, R J, Nash, S, Weiner, L M, Catalano, R C, Ozols, R F, O'Dwyer, P J
Published in Investigational new drugs (1995)
Published in Investigational new drugs (1995)
Get more information
Journal Article
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: A phase II trial of the Fox Chase Network
HAAS, Naomi B, GIANTONIO, Bruce J, HUDES, Gary R, LITWIN, Samuel, MINNITI, Carl J, FOX, Stephen, YESLOW, Gwen, REILLY, Robert, NAHUM, Kenneth, GREENBERG, Richard, HALBHERR, Theresa
Published in Cancer (01.11.2003)
Published in Cancer (01.11.2003)
Get full text
Journal Article